Carcinoid Syndrome - 50 Studies Found
Completed |
: Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors :
: 2003-03-06 : |
Completed |
: Gastrointestinal Motility in Patients With Neuroendocrine Tumors : Neuroendocrine Tumor : 2008-11-11 : Device: Magnetic Tracking System (MTS) and radio-opaque markers MTS: A small magnetic pill (6x15mm) is s |
Completed |
: Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs : Acromegaly : 2011-06-09 : Other: Oral Glucose Tolerance Test (OGTT) An OGTT is a test that lowers growth hormone in the body to ve |
Completed |
: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors :
: 2008-01-25 :
|
Completed |
: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors :
|
Terminated |
: Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome : Malignant Carcinoid Syndrome : 2004-09-22 :
|
Withdrawn |
: Study of Panitumumab in the Treatment of Carcinoid Syndrome : Carcinoid Syndrome : 2010-07-28 : Drug: Panitumumab Panitumumab will be given by intravenous infusion at a dose of 9 mg/kg on day 1 of stu |
Completed |
: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome : Symptoms of Carcinoid Syndrome : 2010-04-12 :
|
Completed |
: Effects of Serotonin Excess on Bone in Carcinoid Syndrome : Carcinoid Syndrome : 2011-08-26 |
Completed |
: Telotristat Etiprate for Carcinoid Syndrome Therapy : Carcinoid Syndrome : 2014-02-12 :
|